Skip to main content
Fig. 4 | Molecular Cancer

Fig. 4

From: Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma

Fig. 4

Histological characterization and biomarkers expression analysis of MPMOs. A Bright-field (BF) microscopy images of MPMOs together with hematoxylin-eosin (HE) stain histological analysis of MPM tissues and MPMOs. All of the MPMOs were the second generation. HE Scale bar, 20 μm. BF Scale bar, 100 μm. B Multiple immuoflurescence staining of cytokeratin 5/6 (CK5/6), Wilms tumor (WT-1), calretinin on MPM-derived organoids and the paimary tumors. CK5/6, red;WT-1, green;Calretinin, pink. 40X Scale bar (20 μm), 100X Scale bar (10 μm), 200X Scale bar (5 μm)

Back to article page

Molecular Cancer

ISSN: 1476-4598